Topics

Symptom Management, Risk Stratification Crucial in MPN Treatment

16:59 EDT 9 Jul 2019 | OncLive

James M. Rossetti, DO, discusses strategies for symptom management, tools available for risk stratification, and updated data with some of the pivotal agents in myeloproliferative neoplasms.

Original Article: Symptom Management, Risk Stratification Crucial in MPN Treatment

NEXT ARTICLE

More From BioPortfolio on "Symptom Management, Risk Stratification Crucial in MPN Treatment"

Quick Search